<span style="color: #222222;">AIIMS Delhi has started the registration process for conducting the human trials of COVAXIN  yesterday. Principal Investigator for conducting these trials Dr. Sanjay Rai said that the response for registration on the very first day has been overwhelming. He informed that around 1,800 applicants have forwarded their requests to volunteer for the human trials.<br />''<br />''In the first phase of trials at AIIMS, the vaccine indigenously developed  by Bharat Biotech will be administered on 100 healthy individuals.<br />''<br />''Speaking exclusively to AIR, NEWS, Dr. Rai informed that the AIIMS Ethics Committee has formulated stringent protocols ensuring safety of volunteers. He informed that the second phase of the human clinical trial will begin after one month of the commencement of the primary phase. Dr. Rai said that the first dose of the vaccine is likely to be administered to the volunteers on Thursday.</span><br />